Acute and chronic wounds impose a substantial burden on the global health care system driven by factors such as ageing populations, obesity and diabetes. Infections, amputations and mortality as a consequence of a wound are becoming more common and may be avoidable with accurate diagnosis and early appropriate treatment.1
Better wound care, including effective diagnosis, treatment and prevention of wound complications, will help to minimise treatment costs.2
annual incidence of wounds in the EU
average cost of a leg ulcer in the EU
patients treated for a acute or chronic wound by the NHS between 2012-13 at a cost of £4.5-£5.2bn
average cost of a foot ulcer in the EU
of the EU health care budget is spent on leg and foot ulcers
Management of wounds is costly: 2,3
of amputations are preceded by ulcers
mortality rate following amputation
Reduced quality of life
The impact on patients can be life changing: 1,4
Improve healing outcomes with single-use NPWT
Traditionally treatment of chronic and acute wounds with NPWT consisted of a foam or gauze dressing customised to the wound size and then connected to a large rechargable pump unit with canister.
Technological advances in recent years have seen NPWT become more discreet, less intrusive for patients and more accessible meaning that more patients can benefit from accelerated healing in complex wounds.
The mechanism of action of NPWT has multiple benefits on an open wound:5,6
- Reduces tissue oedema
- Wound contraction via applied strain
- Increases perfusion
- Stimulates of angiogensis
- Formation of granulation tissue
Avelle™ brings you the full benefits of NPWT in a small, portable, single-use pump with an all-in-one Hydrofiber® Technology dressing – reducing interference with daily life and providing unrestricted mobility for patients.
Choosing the right NPWT System can help improve outcomes in acute and chronic wounds.
How the Avelle™ NPWT System
supports wound management:
All-in-one dressing available in a range of sizes to suit wounds in different antomical areas.
Gels on contact with wound fluid and locks in bacteria keeping it away from surrounding skin.
Small, portable pump allows patients to stay active whilst receiving therapy.
Proven to deliver 80mmHg (±20 mmHg) continuous therapy to the wound bed.
30 day pump lifespan
One pump for up to 30 days of therapy* avoids the need for weekly or bi-weekly pump replacements with alternative single-use NPWT devices.
7 day wear time
Depending on the level of exudate the Avelle™ NPWT dressing can remain in place for up to 7 days helping you to optimise dressing changes.
Provides a viral, bacterial and showerproof barrier.
Avelle™ NPWT System - Wound Management Algorithm
The Avelle™ NPWT System is intended for use on wounds with low to moderate exudate levels and for deeper wounds up to 2cm can be combined with AQUACEL® Extra or gauze filler dressings. The Avelle™ NPWT System can be used in conjunction with compression therapy if required.
The following steps should be taken to ensure patient and wound suitability for the Avelle™ NPWT System.
Read a few of countless Avelle™ NPWT success stories across a variety of surgical indications and challenging wound applications.
“We are still looking for best solution in wound healing disorders, effective both in prophylaxis, as well in hospital and ambulatory treatment. There are many options and ideas, but if you are looking for a “swiss-knife” in wound treatment – think about Avelle™. It is a very universal dressing, easy to apply, easy to remove, effective in prophylaxis, but also very useful in treatment of early complications. Great link between hospital and outpatient clinic, sometimes an ideal option is to continue treatment at home, with a high level of patient satisfaction. Wounds like to be treated by Avelle™…”
“I have used Avelle on 11 patients to improve take of split-thickness skin grafts. Based on our experience, we believe that Avelle™ has helped achieve this by preventing haematoma, improving the local vascular supply and promoting graft adherence to the wound bed. We have also used Avelle™ on closed incisions (mammaplasties, abdominoplasties and non-malignant tumour resections) to reduce oedema, enhance local revascularisation and reduce the risk of dehiscence. We find Avelle™ easy to use: it has a single pressure setting and the Hydrofiber® Technology dressing is easy to apply and remove.”
"The great thing about negative pressure therapy is that it brings the edges of the wound together. It also removes excess fluid and thus oedema and improves circulation. The great advantage of using Hydrofiber® Technology wound dressings in negative pressure therapy is that, unlike foams, we can protect the wound edges.”
“We use it mainly on dehisced orthopaedic surgical incisions and usually use Avelle™ for 3–4 weeks.
In our experience, this promotes granulation tissue formation. The Hydrofiber® Technology dressing helps protect the peri-wound skin: no maceration has been reported in the patients on whom we have used Avelle™ since its introduction into our department almost a year ago.”
“I used AvelleTM as prophylaxis in foot and ankle surgeries to avoid complications such as necrosis and dehiscence. It has been a great advantage, because we manage to avoid those problems that would mean months of treatment to close them by secondary intention. Moreover it has been easy, thanks to the pump duration, not to be worried about which day the patient has to come to the Hospital, and the Hydrofiber® Technology dressing”.
“Avelle™ has had a positive impact on several wound types in my practice including sinus wounds, dehisced abdominal hysterectomy wounds, achilles tendon wounds healing by secondary intention and, possibly controversially given the lack of clinical evidence, post-abdominoplasty to prevent seroma formation. We have not observed any pain or skin trauma during Avelle™ dressing changes. On average, we use Avelle™ for 2–4 weeks on each patient. A key benefit is that the device can be used for up to 30 days.”
“I have used AvelleTM on a wide range of different wounds, and in the same way as any other NPWT treatments. Avelle™ has been useful as a prophylactic treatment for high-risk patients immediately after surgery or after surgical site infection revision surgery. We have seen positive wound healing progression from the start of treatment, leading to very good wound healing outcomes.”